Why Dubai is the New Wealth Hub for Indian Ultra High Net Worth Families | Rohit Nanani

Aditya Khemka predicts Healthcare to boom in 2025 | @NDTVProfitIndia

GLP-1 Mania: Why Most Will Miss the Margins | Aditya Khemka | @CMBCTV18 tag them on YT

Aditya Sood on Concentrated Portfolios and the Road Ahead | @CNBC-TV18

Investing in Hybrid Funds is a trend which is here to stay | Nitin Rao | @CNBC-TV18

Uncertainty creates opportunity | Aditya Khemka | @NDTVProfitIndia

The Next Big Opportunity in Healthcare Investing | Aditya Khemka

✨ 𝐂𝐞𝐥𝐞𝐛𝐫𝐚𝐭𝐞 𝐭𝐡𝐞 𝐩𝐨𝐰𝐞𝐫 𝐨𝐟 𝐩𝐫𝐨𝐬𝐩𝐞𝐫𝐢𝐭𝐲 𝐭𝐡𝐢𝐬 𝐍𝐚𝐯𝐫𝐚𝐭𝐫𝐢 ✨

Aditya Sood on Hidden Opportunities Amid Market Volatility | @CNBC-TV18

Pramod Amthe on Indian Markets: Earnings Outlook, Stock Ideas, and Sector Trends

Bino Pathiparampil, Director – Research, InCred Capital in conversation with CNBC TV18

Will Relief Rally Continue? | Rishi Kohli | @moneycontrol

The CDMO space, we like this space a lot; the problem has been valuation | Aditya Sood | @CNBC-TV18

Trade War Fallout: Indian Pharma in the Crosshairs? | Aditya Khemka | @CNBC-TV18

Finding Opportunity in Fear, Strategy for Value Investors | Aditya Sood | @CNBC-TV18

Market poised to correct further? | Rishi Kohli | InCred Alternative Investments | Money Control

Can Nifty, Sensex extend bull run to third straight day? | Aditya Khemka | @moneycontrol

Why Generic Pharma Faces Headwinds: Aditya Khemka Breaks Down Tariff Risks & Sector Strategy

Focusing on Domestic Growth and Quality Stocks | Aditya Sood | @BusinessToday

We see opportunities in sectors that are currently facing headwinds like MFI | @CNBC-TV18

InCred Growth Partners Fund–II | English Version | Investing in India’s Next Growth Story.

How to invest in the Pharma Sector? | Aditya Khemka | InCred Asset Management | NDTV Profit

Vijay Kuppa On InCred Cap Acquires Orowealth, Enters Retail Wealth Tech Industry | Startup Street

InCred Growth Partners Fund–II | Hindi Version | Investing in India’s Next Growth Story.

Unlocking Pharma & Healthcare Growth | Aditya Khemka | @BusinessToday

Pharma API: A Better China+1 Opportunity | Aditya Khemka | @moneycontrol

Long-term earnings trajectory is inline with the nominal GDP growth | Aditya Sood | @CNBC-TV18

Top Sector Bets & Investment Philosophy | Aditya Sood | @BusinessToday

Volatility Is the New Normal | Rishi Kohli | @moneycontrol

Aditya Khemka Sheds Light on the Pharma Sector

News Update 10 Mar 23 Top 5